KREJČÍ, Pavel, Lisa SALAZAR, Helen GOODRIDGE, Tamara KASHIWADA, Matthew SCHIBLER, Petra JELÍNKOVÁ, Leslie Michels THOMPSON, and William WILCOX. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes. JOURNAL OF CELL SCIENCE. 2008, vol. 121, No 3, p. 272-81, 11 pp. ISSN 0021-9533.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes
Authors KREJČÍ, Pavel (203 Czech Republic, guarantor, belonging to the institution), Lisa SALAZAR (840 United States of America), Helen GOODRIDGE (840 United States of America), Tamara KASHIWADA (840 United States of America), Matthew SCHIBLER (840 United States of America), Petra JELÍNKOVÁ (203 Czech Republic), Leslie Michels THOMPSON, (840 United States of America) and William WILCOX (840 United States of America).
Edition JOURNAL OF CELL SCIENCE, 2008, 0021-9533.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 6.247
RIV identification code RIV/00216224:14310/08:00067178
Organization unit Faculty of Science
UT WoS 000253425600004
Keywords in English FACTOR RECEPTOR-3 FGFR3; THANATOPHORIC DYSPLASIA; SERINE PHOSPHORYLATION; INHIBITS PROLIFERATION; INTERFERON-GAMMA; PC12 CELLS; ACTIVATION; INDUCTION; KINASE; APOPTOSIS
Changed by Changed by: prof. Ing. Petr Dvořák, CSc., učo 47260. Changed: 29/4/2014 09:44.
Abstract
Activating mutations in fibroblast growth factor receptor 3 (FGFR3) cause several human skeletal dysplasias as a result of attenuation of cartilage growth. It is believed that FGFR3 inhibits chondrocyte proliferation via activation of signal transducers and activators of transcription ( STAT) proteins, although the exact mechanism of both STAT activation and STAT-mediated inhibition of chondrocyte growth is unclear. We show that FGFR3 interacts with STAT1 in cells and is capable of activating phosphorylation of STAT1 in a kinase assay, thus potentially serving as a STAT1 kinase in chondrocytes. However, as demonstrated by western blotting with phosphorylation-specific antibodies, imaging of STAT nuclear translocation, STAT transcription factor assays and STAT luciferase reporter assays, FGF does not activate STAT1 or STAT3 in RCS chondrocytes, which nevertheless respond to a FGF stimulus with potent growth arrest. Moreover, addition of active STAT1 and STAT3 to the FGF signal, by means of cytokine treatment, SRC-mediated STAT activation or expression of constitutively active STAT mutants does not sensitize RCS chondrocytes to FGF-mediated growth arrest. Since FGF-mediated growth arrest is rescued by siRNA-mediated downregulation of the MAP kinase ERK1/2 but not STAT1 or STAT3, our data support a model whereby the ERK arm but not STAT arm of FGF signaling in chondrocytes accounts for the growth arrest phenotype.
Links
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
PrintDisplayed: 7/5/2024 09:45